Skip to main content
. 2011 Oct 10;23(5):1138–1144. doi: 10.1093/annonc/mdr438

Figure 2.

Figure 2.

Kaplan–Meier estimates of disease-free survival according to ESR1 status (A) and according to ESR1 status and HER2 status categories (B). HER2, human epidermal growth factor receptor-2.